These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. [Effect of nifedipine on ocular pulse amplitude in normal pressure glaucoma]. Schmidt KG; von Rückmann A; Geyer O; Mittag TW Klin Monbl Augenheilkd; 1997 Jun; 210(6):355-9. PubMed ID: 9333660 [TBL] [Abstract][Full Text] [Related]
28. The influence of magnesium on visual field and peripheral vasospasm in glaucoma. Gaspar AZ; Gasser P; Flammer J Ophthalmologica; 1995; 209(1):11-3. PubMed ID: 7715920 [TBL] [Abstract][Full Text] [Related]
29. Intracellular calcium, myosin light chain phosphorylation, and contractile force in experimental cerebral vasospasm. Bulter WE; Peterson JW; Zervas NT; Morgan KG Neurosurgery; 1996 Apr; 38(4):781-7; discussion 787-8. PubMed ID: 8692399 [TBL] [Abstract][Full Text] [Related]
30. Dihydropyridines and vascular diseases. Tamargo J; Delpón E Z Kardiol; 1991; 80 Suppl 7():106-11. PubMed ID: 1792815 [TBL] [Abstract][Full Text] [Related]
31. [Vascular and neuronal mechanisms of calcium antagonists. Significance in neurological therapy]. Govoni S; Trabucchi M; Battaini F; Magnoni MS; Paoletti R Minerva Med; 1986 Jun; 77(24):1053-8. PubMed ID: 3725133 [TBL] [Abstract][Full Text] [Related]
32. Cerebral vasospasm. De Salles AA Arq Neuropsiquiatr; 1987 Sep; 45(3):329-38. PubMed ID: 3326553 [TBL] [Abstract][Full Text] [Related]
33. [Cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Therapeutic value of treatment with calcium antagonists, hypervolemic hemodilution and induced arterial hypertension]. Hansen D; Hannemann L; Specht M; Schaffartzik W Anaesthesist; 1995 Apr; 44(4):219-29. PubMed ID: 7785750 [TBL] [Abstract][Full Text] [Related]
34. Regional coronary vasoconstriction after combined beta-adrenergic and calcium channel blockade in patients with coronary artery disease. Kern MJ; Petru MA; Ferry DR; Eilen SD; Barr WK; Porter CB; O'Rourke RA J Am Coll Cardiol; 1985 Jun; 5(6):1438-50. PubMed ID: 2860147 [TBL] [Abstract][Full Text] [Related]
35. [Comparative study of nicardipine versus placebo in the prevention of cognitive deterioration in patients with transient ischemic attack]. Moltó JM; Falip R; Martín R; Insa R; Pastor I; Matías-Guiu J Rev Neurol; 1995; 23(119):54-8. PubMed ID: 8548644 [TBL] [Abstract][Full Text] [Related]
36. Influence of physical exercise and nifedipine on ocular pulse amplitude. Schmidt KG; Mittag TW; Pavlovic S; Hessemer V Graefes Arch Clin Exp Ophthalmol; 1996 Aug; 234(8):527-32. PubMed ID: 8858360 [TBL] [Abstract][Full Text] [Related]
37. Clinical potential of lomerizine, a Ca2+ channel blocker as an anti-glaucoma drug: effects on ocular circulation and retinal neuronal damage. Hara H; Toriu N; Shimazawa M Cardiovasc Drug Rev; 2004; 22(3):199-214. PubMed ID: 15492768 [TBL] [Abstract][Full Text] [Related]
38. Treatment of vasospasm due to subarachnoid hemorrhage with calcium entry blockers. Przuntek H; von Baumgarten F; Mertens HG Eur Neurol; 1986; 25 Suppl 1():86-92. PubMed ID: 3530777 [TBL] [Abstract][Full Text] [Related]
39. Quantitative middle cerebral artery flow in normal and vasospastic arteries. Austin G; Gaskell R Neurol Res; 1992; 14(2 Suppl):192-6. PubMed ID: 1355887 [TBL] [Abstract][Full Text] [Related]
40. [Current aspects of drug correction of impaired circulation in the ocular vessels]. Kiseleva TN; Polunin GS; Lagutina IuM Vestn Oftalmol; 2007; 123(2):37-9. PubMed ID: 17650609 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]